import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰åœ–æ›¸é¤¨ (2026 æ——è‰¦å…¨åŠŸèƒ½æ•´åˆç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

# åˆå§‹åŒ– session_state
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = "ğŸ“š RUBY"

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === æ¥µè‡´ç·Šç·»åŒ– UI === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9; color: #1A1A1A;
        font-size: 19px !important; line-height: 1.1;
    }

    .main-title {
        font-size: 30px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 2px 10px rgba(0,0,0,0.08);
        border: 2px solid transparent; background: white; 
        margin-bottom: 4px; overflow: hidden; height: auto !important;
    }
    .big-stage-header {
        font-size: 17px !important; font-weight: 900; color: white;
        padding: 5px; text-align: center;
    }

    .sub-block {
        margin: 2px 4px; padding: 4px; border-radius: 6px; 
        background: #F8F9FA; border-left: 5px solid #546E7A;
    }
    .sub-block-title {
        font-size: 13px; font-weight: 900; color: #37474F;
        margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
    }

    /* æŒ‰éˆ•æ¨£å¼ï¼šæ·±é»‘è‰²åŠ ç²— (#1A1A1A) */
    .stPopover button { 
        font-weight: 900 !important; font-size: 11px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }
    .stPopover button[aria-label*="ğŸ“"] { background: #E1F5FE !important; border-left: 5px solid #0288D1 !important; } 

    .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 40px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å°èˆªæ•¸æ“šåº«ï¼šå…¨éšæ®µã€MOCã€PSOC/PROC ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "MMRd / MSI-H / dMMR", "content": "ä¸€ç·šé¦–é¸ï¼šChemo + PD-1 (RUBY/GY018/AtTEnd)ã€‚"},
            {"title": "NSMP / pMMR / MSS", "content": "æ’é™¤åˆ†å‹ã€‚è¦– ER/Grade æ±ºç­–ï¼›ä¸€ç·šåŠ ç¶­æŒ (DUO-E)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "ä¸€ç·š IO æ²»ç™‚å¾Œå»¶çºŒç¶­æŒè‡³é€²å±• (PD)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "Recurrent EC", "content": "æ¨™é¶+å…ç–« (MSS) æˆ– IO å–®è—¥ (GARNET/MMRd)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ° PDã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "Surgery + Carbo/Pacli Â± Bevã€‚è€ƒæ…® IDS + HIPEC (van Driel)ã€‚"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "åˆ¤å®šï¼šCK7+/SATB2- (åŸç™¼)ã€‚1. Expansile: é å¾Œä½³ã€‚ 2. Infiltrative: å»ºè­°åŒ–ç™‚ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "Olaparib ç¶­æŒ 2å¹´ (SOLO-1)ã€‚"}, {"title": "HRD positive (wt)", "content": "PAOLA-1 (Ola+Bev) æˆ– PRIMA (Nira)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC (Sensitive)", "content": "PFI > 6mã€‚è©•ä¼°äºŒæ¬¡æ‰‹è¡“ (DESKTOP III) æˆ–å«é‰‘é›™è—¥ã€‚"},
            {"title": "PROC (Resistant)", "content": "PFI < 6mã€‚å–®è—¥åŒ–ç™‚ Â± Bev æˆ–æ¨™é¶ ADC (MIRASOL)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive Maint", "content": "æ•‘æ´ç·©è§£å¾Œé¸ PARPi ç¶­æŒ (NOVA/ARIEL3/SOLO2)ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Locally Advanced (CCRT)", "content": "åŒæ­¥åŒ–æ”¾ç™‚ Â± IO (A18) æˆ– èª˜å°åŒ–ç™‚ (INTERLACE)ã€‚"},
            {"title": "Early Stage (Surgery)", "content": "æ ¹æ²»è¡“ (LACC) æˆ–å–®ç´”åˆ‡é™¤ (SHAPE)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "Recurr / Metastatic", "content": "ä¸€ç·š Pembro+åŒ–ç™‚Â±Bev (KN826) æˆ– Atezoçµ„åˆ (BEATcc)ã€‚äºŒç·š ADC (innovaTV 301)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ° PDã€‚"}]}
    ]
}

# --- 2. ç¶œåˆå¯¦è­‰é‡Œç¨‹ç¢‘è³‡æ–™åº« (25é …å…¨æ•¸æ­¸ç´) ---
milestone_db = [
    # --- Endometrial ---
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H / dMMR"], "name": "ğŸ“š RUBY", "pharma": "GSK", "drug": "Dostarlimab + CP", 
     "rationale": "PD-1 é˜»æ–·èˆ‡å«é‰‘åŒ–ç™‚å…·å‚™å”åŒ ICD æ•ˆæ‡‰ã€‚", 
     "regimen": "Dostarlimab 500mg Q3W + CP x6é€±æœŸ -> ç¶­æŒ 1000mg Q6W æœ€é•· 3å¹´ã€‚",
     "inclusion": ["FIGO III-IV æœŸæˆ–é¦–æ¬¡å¾©ç™¼ ECã€‚", "åŒ…å« Carcinosarcoma å‹æ…‹ã€‚"],
     "results": "dMMR: HR 0.32; mOS 44.6m (vs 28.2m, HR 0.69)."},
    
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["NSMP / pMMR / MSS"], "name": "ğŸ“š DUO-E", "pharma": "AZ", "drug": "Durvalumab + CP -> ç¶­æŒ Â± Olaparib", 
     "rationale": "æ¢ç´¢ PARPi æ–¼ pMMR æ‚£è€…å…ç–«ç¶­æŒä¹‹å”åŒæ•ˆæ‡‰ã€‚",
     "results": "ä¸‰è—¥çµ„ PFS HR 0.57 (vs CP); dMMR çµ„ HR 0.42."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H / dMMR"], "name": "ğŸ“š AtTEnd", "pharma": "Roche", "drug": "Atezolizumab + CP", 
     "results": "dMMR PFS HR 0.36; ITT OS HR 0.82 (P=0.048)."},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š KEYNOTE-775", "pharma": "MSD/Eisai", "drug": "Lenvatinib + Pembro", 
     "results": "pMMR OS HR 0.68; mOS 17.4m vs 12.0m. ç¢ºç«‹ MSS äºŒç·šæ¨™æº–ã€‚"},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š GARNET", "pharma": "GSK", "drug": "Dostarlimab (Single)", 
     "results": "dMMR/MSI-H ORR 45.5%; DOR æœªé”åˆ°ã€‚"},

    # --- Cervical ---
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š KEYNOTE-A18", "pharma": "MSD", "drug": "Pembrolizumab + CCRT", 
     "results": "OS HR 0.67; 36m OS 82.6% (vs 74.8%)."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š INTERLACE", "pharma": "UCL", "drug": "Induction Carbo/Pacli x6", 
     "results": "5yr OS 80% (vs 72%, HR 0.60)."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š CALLA", "pharma": "AZ", "drug": "Durvalumab + CCRT", 
     "results": "PFS HR 0.84 (P=NS). é™°æ€§è©¦é©—æé†’éœ€æ›´ç²¾æº–åˆ†æµã€‚"},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š KEYNOTE-826", "pharma": "MSD", "drug": "Pembro + åŒ–ç™‚ Â± Bev", 
     "results": "OS HR 0.63 (ITT); HR 0.60 (CPSâ‰¥1)."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š BEATcc", "pharma": "Roche", "drug": "Atezo + Chemo + Bev", 
     "results": "PFS HR 0.62; OS HR 0.68."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š EMPOWER-Cx 1", "pharma": "Regeneron", "drug": "Cemiplimab", 
     "results": "OS HR 0.69; mOS 12.0m vs 8.5m."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š innovaTV 301", "pharma": "Seagen", "drug": "Tisotumab Vedotin (ADC)", 
     "results": "OS HR 0.70; ORR 17.8% (vs 5.2%)."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early Stage (Surgery)"], "name": "ğŸ“š SHAPE trial", "pharma": "UCL/CCTG", "drug": "Simple Hysterectomy", 
     "results": "3yr Recurrence: 2.5% vs 2.2% (ä¸åŠ£æ€§é”æˆ)ã€‚"},

    # --- Ovarian ---
    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutated"], "name": "ğŸ“š SOLO-1", "pharma": "AZ", "drug": "Olaparib ç¶­æŒ", 
     "results": "7yr survival 67% (HR 0.33); ITT æœªé”åˆ°ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)", "HRD negative / pHRD"], "name": "ğŸ“š PRIMA", "pharma": "GSK", "drug": "Niraparib ç¶­æŒ", 
     "results": "HRD+ PFS HR 0.43; å…¨äººç¾¤ HR 0.62."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š PAOLA-1", "pharma": "AZ", "drug": "Olaparib + Bevacizumab", 
     "results": "HRD+ OS HR 0.62; 5yr OS 75.2%."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutated", "HRD positive (wt)"], "name": "ğŸ“š ATHENAâ€“MONO", "pharma": "Clovis", "drug": "Rucaparib ç¶­æŒ", 
     "results": "ITT PFS HR 0.52 (28.7m vs 11.3m)."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š NOVA", "pharma": "GSK", "drug": "Niraparib ç¶­æŒ", 
     "results": "gBRCA HR 0.27; Non-gBRCA HR 0.45."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š ARIEL3", "pharma": "Clovis", "drug": "Rucaparib ç¶­æŒ", 
     "results": "BRCAm HR 0.23; HRD+ HR 0.32."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š SOLO2", "pharma": "AZ", "drug": "Olaparib ç¶­æŒ", 
     "results": "mOS 51.7m vs 38.8m; HR 0.74."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š DUO-O", "pharma": "AZ", "drug": "Durva+Ola+Bev ç¶­æŒ", 
     "results": "HRD+ PFS HR 0.49."},

    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"], "name": "ğŸ“š MIRASOL", "pharma": "ImmunoGen", "drug": "Mirvetuximab", 
     "results": "OS HR 0.67; ORR 42.3%. PROC æ­·å²æ€§çªç ´ã€‚"},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š van Driel HIPEC", "pharma": "NEJM 2018", "drug": "Surgery + HIPEC", 
     "results": "mOS 45.7m vs 33.9m (HR 0.67)."},

    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PSOC (Sensitive)"], "name": "ğŸ“š DESKTOP III", "pharma": "NEJM 2021", "drug": "Secondary Surgery", 
     "results": "mOS 53.7m vs 46.0m (HR 0.75)."},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š LION", "pharma": "NEJM 2019", "drug": "No Lymphadenectomy", 
     "results": "OS HR 1.06 (P=0.65)ã€‚è‡¨åºŠ LN é™°æ€§å…æ¸…æƒã€‚"},
]

# --- 3. æ‹›å‹Ÿä¸­è‡¨åºŠè©¦é©—è³‡æ–™åº« (8æ ¸å¿ƒè£œé½Š) ---
ongoing_trials = [
    {"cancer": "Ovarian", "name": "ğŸ“ FRAmework-01", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"], "type": "Ongoing",
     "rationale": "æ¨™é¶ FRÎ± ADCã€‚è¯ç”¨ Bevacizumab ç”¢ç”Ÿè¡€ç®¡èª¿ç¯€å”åŒä½œç”¨ (Synergy)ï¼Œæå‡è—¥ç‰©æ»²é€æ·±åº¦ä¸¦é€éæ—è§€è€…æ•ˆæ‡‰æ®ºå‚·ä½è¡¨é”ç´°èƒã€‚",
     "regimen": "LY4170156 3mg/kg IV + Bevacizumab 15mg/kg IV Q3Wã€‚",
     "inclusion": ["HG Serous / Carcinosarcoma åµå·¢ç™Œã€‚", "ç¶“æª¢æ¸¬ç¢ºèª FRÎ± è¡¨é”é™½æ€§ã€‚", "æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©å…§æƒ¡åŒ– (PROC)ã€‚"],
     "exclusion": ["æ›¾ç”¨é Topo I ADC (Enhertu)ã€‚", "æ´»å‹•æ€§é–“è³ªæ€§è‚ºç—… (ILD)ã€‚"], "results": "Ongoing Recruitment."},

    {"cancer": "Ovarian", "name": "ğŸ“ REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCã€‚å…·æ¥µé«˜ DAR (8) èˆ‡å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰ï¼Œå°ˆæ”»ç•°è³ªæ€§ PROCã€‚",
     "regimen": "R-DXd 5.6mg/kg IV Q3Wã€‚",
     "inclusion": ["HG Serous æˆ– Endometrioid PROCã€‚", "æä¾›åˆ‡ç‰‡åˆ¤å®š CDH6 åˆ†å±¤ã€‚"],
     "exclusion": ["Low-grade è…«ç˜¤ã€‚", "LVEF < 50%ã€‚"], "results": "ORR ~46% in Phase 1 Expansion."},

    {"cancer": "Ovarian", "name": "ğŸ“ TroFuse-021", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD positive (wt)", "HRD negative / pHRD"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Trop-2 ADCã€‚é€éçµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°ä¹‹ ICD æ•ˆæ‡‰ï¼Œå„ªåŒ–ç¶­æŒéšæ®µç²ç›Šã€‚",
     "regimen": "Sac-TMT Q3W + Bevacizumab ç¶­æŒã€‚",
     "inclusion": ["æ–°è¨ºæ–· Stage III/IV åµå·¢ç™Œã€‚", "ä¸€ç·šå«é‰‘åŒ–ç™‚å¾Œé” CR æˆ– PRã€‚"],
     "exclusion": ["BRCA è®Šç•°è€…ã€‚", "å…ˆå‰ç”¨éé‡å° Trop-2 ä¹‹ ADC è—¥ç‰©ã€‚"], "results": "Phase 3 Recruitment."},

    {"cancer": "Endometrial", "name": "ğŸ“ MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembrolizumab", "pos": "P-MT", "sub_pos": ["IO Maintenance"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1ã€‚é€éå…ç–«åŸæ€§èª¿ç¯€å¼·åŒ– Pembro åœ¨ pMMR æˆ– NSMP æ—ç¾¤æ‡‰ç­”ã€‚",
     "regimen": "Pembro 400mg Q6W + Sac-TMT 5mg/kg Q6Wã€‚",
     "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)ã€‚", "FIGO III/IV ä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PRã€‚"],
     "exclusion": ["å…ˆå‰æ¥å—éæ™šæœŸç³»çµ±æ€§ IO æ²»ç™‚ã€‚"], "results": "Phase 3 Recruiting."},
    
    {"cancer": "Endometrial", "name": "ğŸ“ GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Trop-2 ADCã€‚åˆ©ç”¨ SN-38 è¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡èˆ‡å…ç–«å¤±æ•—æ•‘æ´ã€‚",
     "regimen": "SG 10mg/kg (D1, D8 Q21D)ã€‚",
     "inclusion": ["å¾©ç™¼æ€§ EC (ä¸å«è‚‰ç˜¤)ã€‚", "é‰‘é¡èˆ‡ PD-1 å¤±æ•—å¾Œé€²å±•ã€‚"],
     "exclusion": ["å…ˆå‰ç”¨é Trop-2 ADCã€‚"], "results": "ORR ~28% in Phase 2."},

    {"cancer": "Ovarian", "name": "ğŸ“ DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd (HER2 ADC)", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "type": "Ongoing",
     "rationale": "æ¨™é¶ HER2 ADCã€‚æ•‘æ´åŒ–ç™‚ç©©å®šå¾Œç²¾æº–ç¶­æŒï¼Œæ¸…é™¤ HER2 è¡¨ç¾ç™Œç´°èƒæ®˜ç•™ç—…ç¶ã€‚",
     "regimen": "T-DXd 5.4mg/kg IV Q3Wã€‚",
     "inclusion": ["HER2 IHC 1+/2+/3+ ç¢ºèªã€‚", "PSOC æ•‘æ´åŒ–ç™‚é”ç©©å®š (Non-PD)ã€‚"],
     "exclusion": ["ILD è‚ºéƒ¨ç—…å²ã€‚"], "results": "Phase 3 Access."},

    {"cancer": "Ovarian", "name": "ğŸ“ DOVE", "pharma": "GSK", "drug": "Dostarlimab + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"], "type": "Ongoing",
     "rationale": "é‡å° OCCC é€æ˜ç´°èƒç™Œã€‚åˆ©ç”¨ IO + anti-VEGF é›™é‡æ‰“æ“Šï¼Œæ”¹å–„å…¶ç‰¹æœ‰å…ç–«æŠ‘åˆ¶ç’°å¢ƒã€‚",
     "regimen": "Dostarlimab 1000mg Q6W + Bev Q3Wã€‚",
     "inclusion": ["çµ„ç¹”å­¸ OCCC > 50%ã€‚", "é‰‘é¡æŠ—è—¥æ€§ (PFI < 12m)ã€‚"],
     "exclusion": ["å…ˆå‰ç”¨éä»»ä½•å…ç–«æ²»ç™‚ã€‚"], "results": "Phase 2 Recruiting."},

    {"cancer": "Cervical", "name": "ğŸ“ innovaTV 301 Access", "pharma": "Seagen", "drug": "Tisotumab Vedotin (Tivdak)", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Tissue Factor (TF) ADCã€‚æ—¨åœ¨å…‹æœå¾Œç·šå­å®®é ¸ç™ŒåŒ–ç™‚è€è—¥æ€§ã€‚",
     "inclusion": ["å¾©ç™¼/è½‰ç§»å­å®®é ¸ç™Œã€‚", "å…ˆå‰æ¥å— 1â€“2 ç·šæ²»ç™‚å¾Œé€²å±•ã€‚"],
     "exclusion": ["åš´é‡çœ¼ç–¾æˆ–è§’è†œç‚ã€‚"], "results": "Post-FDA Access Trial."},
]

# --- 4. å‹•æ…‹æ¨¡å‹å·¡é‚èˆ‡ AI æ¨¡å‹é¸æ“‡ ---
def get_gemini_model():
    try:
        available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
        target_model = None
        for m in available_models:
            if 'gemini-1.5-flash' in m: target_model = m; break
        if not target_model:
            for m in available_models:
                if 'gemini-pro' in m or 'gemini-1.5-pro' in m: target_model = m; break
        if target_model: return genai.GenerativeModel(target_model)
    except: return None

# --- 5. å´é‚Šæ¬„ ---
with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰åª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ ç—…æ­·åˆ†æ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥æ‘˜è¦ (åˆ†å‹/æ¨™è¨˜)", height=250)
        if st.button("ğŸš€ é–‹å§‹åˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = get_gemini_model()
                    prompt = f"åˆ†æï¼š{p_notes}ã€‚åƒè€ƒï¼š{milestone_db} åŠ {ongoing_trials}ã€‚æä¾›æ²»ç™‚å»ºè­°ã€‚"
                    st.write(model.generate_content(prompt).text)
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 6. ä¸»é é¢ï¼šå°èˆªåœ°åœ– ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 å¯¦è­‰èˆ‡æ”¶æ¡ˆæ•´åˆç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

cols = st.columns(len(guidelines_nested[cancer_type]))
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            
            # é¡¯ç¤ºå°æ‡‰è©¦é©— (ğŸ“š & ğŸ“)
            rel_trials = [t for t in (milestone_db + ongoing_trials) if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                label = f"{t.get('pharma', 'N/A')} | {t['name']} | {t['drug']}"
                with st.popover(label, use_container_width=True):
                    st.success(f"**æ ¸å¿ƒçµè«–:** {t.get('results', 'æ‹›å‹Ÿä¸­')}")
                    # ä½¿ç”¨å”¯ä¸€éµå€¼è¯å‹•ï¼Œé»é¸å¾Œ rerun åŒæ­¥ä¸‹æ–¹çœ‹æ¿
                    ukey = f"sync_{t['name']}_{cancer_type}_{stage['id']}_{sub['title'].replace(' ', '')}"
                    if st.button("ğŸ“Š åŒæ­¥çœ‹æ¿ç´°ç¯€", key=ukey):
                        st.session_state.selected_trial = t['name']
                        st.rerun()
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 7. è‡¨åºŠè©¦é©—æ·±åº¦æ•¸æ“šåº« (Bottom Selector) ---
st.divider()
st.subheader("ğŸ“‹ è‡¨åºŠè©¦é©—æ·±åº¦æ•¸æ“šåº« (Published Milestones & Ongoing Trials)")
all_list = milestone_db + ongoing_trials
filtered_names = [t["name"] for t in all_list if t["cancer"] == cancer_type]

try: curr_idx = filtered_names.index(st.session_state.selected_trial)
except: curr_idx = 0

selected_name = st.selectbox("ğŸ¯ å¿«é€Ÿé¸æ“‡ç ”ç©¶è¨ˆç•«ä»¥æŸ¥é–±è©³ç´°å…§å®¹ï¼š", filtered_names, index=curr_idx, key="trial_selector")
st.session_state.selected_trial = selected_name # åŒæ­¥é¸ä¸­çš„è¨ˆç•«

t = next(it for it in all_list if it["name"] == selected_name)

st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦æ•¸æ“šåˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

r1, r2 = st.columns([1.3, 1])
with r1:
    st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Rationale & Regimen (æ©Ÿè½‰èˆ‡é…æ–¹)</b></div>", unsafe_allow_html=True)
    st.write(f"**æ ¸å¿ƒä»‹å…¥:** {t['drug']}")
    st.write(f"**è©³ç´°çµ¦è—¥:** {t.get('regimen', t.get('dosing', 'è©³è¦‹æ‹›å‹Ÿç´°å‰‡'))}")
    st.success(t.get('rationale', 'è©²ç ”ç©¶ä¸»è¦é‡å°ç‰¹å®šåˆ†å­åˆ†å‹ï¼Œé€éå‰æ²¿æ¨™é¶æˆ–å…ç–«æ©Ÿåˆ¶æŒ‘æˆ°ç¾æœ‰ SoC ç“¶é ¸ã€‚'))
    
with r2:
    st.markdown("<div style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Key Outcomes (ç”Ÿå­˜èˆ‡ç·©è§£æ•¸æ“š)</b></div>", unsafe_allow_html=True)
    st.markdown(f"""
        <div style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
            <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Survival Metrics (PFS/OS/HR/ORR)</div>
            <div class='hr-big-val'>{t.get('results', 'Recruiting...')}</div>
        </div>
    """, unsafe_allow_html=True)
    
st.divider()
r3, r4 = st.columns(2)
with r3:
    st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¢ä»¶)</b></div>", unsafe_allow_html=True)
    for inc in t.get('inclusion', ['è©³è¦‹å…¨æ–‡ Protocolã€‚']): st.write(f"â€¢ **{inc}**")
with r4:
    st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
    for exc in t.get('exclusion', ['è©³è¦‹å…¨æ–‡ Protocolã€‚']): st.write(f"â€¢ **{exc}**")
st.markdown("</div>", unsafe_allow_html=True)
